Form 4 for MRNA Moderna
Accepted 2021-08-25 00:00:00 ET · period of report 2021-08-23 · accession 0001127602-21-024308 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-25 | 2021-08-23+ | MRNA | Hoge Stephen | Pres | M - OptEx | $5.95 | +20.0K | 1.62M | +1% | +$118.9K |
| DM | 2021-08-25 | 2021-08-23+ | MRNA | Hoge Stephen | Pres | S - Sale+OE | $400.13 | -20.0K | 1.61M | -1% | -$8.00M |
| DM | 2021-08-25 | 2021-08-23+ | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -20.0K | 252.0K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-23 | M | A | 5,000 | $10.90 | 1,614,597 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-24 | S | D | 5,000 | $403.98 | 1,609,597 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-23 | S | D | 300 | $389.39 | 1,624,297 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $389.02 to $390.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2021-08-23 | S | D | 5,000 | $390.11 | 1,619,297 | D | — | — | |
| 5 | Common | Common Stock | 2021-08-23 | S | D | 400 | $392.68 | 1,618,897 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $392.11 to $393.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 6 | Common | Common Stock | 2021-08-23 | S | D | 200 | $393.68 | 1,618,697 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $393.36 to $394.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 7 | Common | Common Stock | 2021-08-23 | S | D | 300 | $395.11 | 1,618,397 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $394.72 to $395.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 8 | Common | Common Stock | 2021-08-23 | S | D | 400 | $396.28 | 1,617,997 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $395.87 to $396.52. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 9 | Common | Common Stock | 2021-08-23 | S | D | 200 | $396.89 | 1,617,797 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $396.88 to $396.89. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 10 | Common | Common Stock | 2021-08-23 | S | D | 800 | $399.16 | 1,616,997 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $398.51 to $399.40. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 11 | Common | Common Stock | 2021-08-23 | S | D | 725 | $400.84 | 1,616,272 | D | — | — | (F9) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $400.41 to $401.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 12 | Common | Common Stock | 2021-08-23 | S | D | 713 | $402.09 | 1,615,559 | D | — | — | (F10) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $401.58 to $402.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 13 | Common | Common Stock | 2021-08-23 | S | D | 1,585 | $403.07 | 1,613,974 | D | — | — | (F11) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $402.61 to $403.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 14 | Common | Common Stock | 2021-08-23 | S | D | 445 | $403.86 | 1,613,529 | D | — | — | (F12) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $403.68 to $404.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 15 | Common | Common Stock | 2021-08-23 | S | D | 400 | $405.08 | 1,613,129 | D | — | — | (F13) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $404.90 to $405.24. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 16 | Common | Common Stock | 2021-08-23 | S | D | 100 | $406.30 | 1,613,029 | D | — | — | |
| 17 | Common | Common Stock | 2021-08-23 | S | D | 800 | $407.98 | 1,612,229 | D | — | — | (F14) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $407.39 to $408.39. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 18 | Common | Common Stock | 2021-08-23 | S | D | 1,100 | $409.07 | 1,611,129 | D | — | — | (F15) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $408.49 to $409.45 Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 19 | Common | Common Stock | 2021-08-23 | S | D | 974 | $410.22 | 1,610,155 | D | — | — | (F16) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $409.72 to $410.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 20 | Common | Common Stock | 2021-08-23 | S | D | 558 | $411.07 | 1,609,597 | D | — | — | (F17) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $410.87 to $411.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 21 | Common | Common Stock | 2021-08-24 | M | A | 5,000 | $10.90 | 1,614,597 | D | — | — | |
| 22 | Common | Common Stock | 2021-08-23 | M | A | 10,000 | $0.99 | 1,624,597 | D | — | — | |
| 23 | Derivative | Stock Option (Right to Buy) | 2021-08-24 | M | D | 5,000 | $0.00 | 246,972 | D | $10.90 · — to 2026-02-23 | 5,000 Common Stock | (F19) 25% of this option vested and became exercisable on February 23, 2017, with the remainder vesting in 12 equal quarterly installments thereafter. |
| 24 | Derivative | Stock Option (Right to Buy) | 2021-08-23 | M | D | 10,000 | $0.00 | 357,431 | D | $0.99 · — to 2023-08-19 | 10,000 Common Stock | (F20) This option is fully vested and exercisable. |
| 25 | Derivative | Stock Option (Right to Buy) | 2021-08-23 | M | D | 5,000 | $0.00 | 251,972 | D | $10.90 · — to 2026-02-23 | 5,000 Common Stock | (F19) 25% of this option vested and became exercisable on February 23, 2017, with the remainder vesting in 12 equal quarterly installments thereafter. |